Resident’s Forum
RF-New Evidence in Favor of 5-Fluorouracil in the Treatment of Actinic Keratosis
FR-Nueva evidencia a favor de 5-fluorouracilo en eltratamiento de las queratosis actínicas
D. Morgado-Carrasco
, X. Fustà-Novell, A. Toll
Corresponding author
Servicio de Dermatología, Hospital Clínic de Barcelona, Barcelona, España
Read
4843
Timeswas read the article
2042
Total PDF
2801
Total HTML
Share statistics
array:25 [ "pii" => "S1578219020303796" "issn" => "15782190" "doi" => "10.1016/j.adengl.2019.04.021" "estado" => "S300" "fechaPublicacion" => "2021-01-01" "aid" => "2461" "copyright" => "AEDV" "copyrightAnyo" => "2020" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "sco" "cita" => "Actas Dermosifiliogr. 2021;112:69-70" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "Traduccion" => array:1 [ "es" => array:20 [ "pii" => "S0001731020303318" "issn" => "00017310" "doi" => "10.1016/j.ad.2019.04.018" "estado" => "S300" "fechaPublicacion" => "2021-01-01" "aid" => "2461" "copyright" => "AEDV" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "sco" "cita" => "Actas Dermosifiliogr. 2021;112:69-70" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Foro de Residentes</span>" "titulo" => "FR-Nueva evidencia a favor de 5-fluorouracilo en el tratamiento de las queratosis actínicas" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "69" "paginaFinal" => "70" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "RF-New Evidence in Favor of 5-Fluorouracil in the Treatment of Actinic Keratosis" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "D. Morgado-Carrasco, X. Fustà-Novell, A. Toll" "autores" => array:3 [ 0 => array:2 [ "nombre" => "D." "apellidos" => "Morgado-Carrasco" ] 1 => array:2 [ "nombre" => "X." "apellidos" => "Fustà-Novell" ] 2 => array:2 [ "nombre" => "A." "apellidos" => "Toll" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S1578219020303796" "doi" => "10.1016/j.adengl.2019.04.021" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219020303796?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731020303318?idApp=UINPBA000044" "url" => "/00017310/0000011200000001/v1_202012220631/S0001731020303318/v1_202012220631/es/main.assets" ] ] "itemSiguiente" => array:20 [ "pii" => "S1578219020303711" "issn" => "15782190" "doi" => "10.1016/j.adengl.2020.12.005" "estado" => "S300" "fechaPublicacion" => "2021-01-01" "aid" => "2465" "copyright" => "AEDV" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "sco" "cita" => "Actas Dermosifiliogr. 2021;112:71" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Images in Dermatology</span>" "titulo" => "Kaposi Varicelliform Eruption on Sunburned Skin" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "71" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Erupción variceliforme de Kaposi sobre quemadura solar" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:6 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 443 "Ancho" => 1755 "Tamanyo" => 104763 ] ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "M. Rogel-Vence, L. González-Ruiz, M. Franco-Muñoz, J.A. Garrido-Martín" "autores" => array:4 [ 0 => array:2 [ "nombre" => "M." "apellidos" => "Rogel-Vence" ] 1 => array:2 [ "nombre" => "L." "apellidos" => "González-Ruiz" ] 2 => array:2 [ "nombre" => "M." "apellidos" => "Franco-Muñoz" ] 3 => array:2 [ "nombre" => "J.A." "apellidos" => "Garrido-Martín" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0001731020303355" "doi" => "10.1016/j.ad.2018.12.013" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731020303355?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219020303711?idApp=UINPBA000044" "url" => "/15782190/0000011200000001/v1_202101161046/S1578219020303711/v1_202101161046/en/main.assets" ] "itemAnterior" => array:20 [ "pii" => "S157821902030367X" "issn" => "15782190" "doi" => "10.1016/j.adengl.2020.12.002" "estado" => "S300" "fechaPublicacion" => "2021-01-01" "aid" => "2435" "copyright" => "AEDV" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2021;112:63-8" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:14 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Brief Comunication</span>" "titulo" => "Merkel Cell Carcinoma: A Description of 11 Cases" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:3 [ 0 => "en" 1 => "en" 2 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "63" "paginaFinal" => "68" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Carcinoma de células de Merkel: estudio descriptivo de 11 casos" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 1 "multimedia" => array:5 [ "identificador" => "fig0015" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => false "mostrarDisplay" => true "figura" => array:1 [ 0 => array:4 [ "imagen" => "fx1.jpeg" "Alto" => 1085 "Ancho" => 1232 "Tamanyo" => 128633 ] ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "E. García-Zamora, M. Vela Ganuza, J. Martín-Alcalde, R. Miñano Medrano, F. Pinedo Moraleda, J.L. López-Estebaranz" "autores" => array:6 [ 0 => array:2 [ "nombre" => "E." "apellidos" => "García-Zamora" ] 1 => array:2 [ "nombre" => "M." "apellidos" => "Vela Ganuza" ] 2 => array:2 [ "nombre" => "J." "apellidos" => "Martín-Alcalde" ] 3 => array:2 [ "nombre" => "R." "apellidos" => "Miñano Medrano" ] 4 => array:2 [ "nombre" => "F." "apellidos" => "Pinedo Moraleda" ] 5 => array:2 [ "nombre" => "J.L." "apellidos" => "López-Estebaranz" ] ] ] ] "resumen" => array:1 [ 0 => array:3 [ "titulo" => "Graphical abstract" "clase" => "graphical" "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><p id="spar0045" class="elsevierStyleSimplePara elsevierViewall"><elsevierMultimedia ident="fig0015"></elsevierMultimedia></p></span>" ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0001731020302805" "doi" => "10.1016/j.ad.2019.04.014" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731020302805?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S157821902030367X?idApp=UINPBA000044" "url" => "/15782190/0000011200000001/v1_202101161046/S157821902030367X/v1_202101161046/en/main.assets" ] "en" => array:16 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Resident’s Forum</span>" "titulo" => "RF-New Evidence in Favor of 5-Fluorouracil in the Treatment of Actinic Keratosis" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "69" "paginaFinal" => "70" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "D. Morgado-Carrasco, X. Fustà-Novell, A. Toll" "autores" => array:3 [ 0 => array:4 [ "nombre" => "D." "apellidos" => "Morgado-Carrasco" "email" => array:1 [ 0 => "morgado@clinic.cat" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "*" "identificador" => "cor0005" ] ] ] 1 => array:2 [ "nombre" => "X." "apellidos" => "Fustà-Novell" ] 2 => array:2 [ "nombre" => "A." "apellidos" => "Toll" ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Servicio de Dermatología, Hospital Clínic de Barcelona, Barcelona, España" "identificador" => "aff0005" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "FR-Nueva evidencia a favor de 5-fluorouracilo en eltratamiento de las queratosis actínicas" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Actinic keratosis (AK) is a highly prevalent premalignant lesion. The risk of progression to squamous cell carcinoma varies between 0% and 0.53% per AK lesion per year.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> A wide variety of therapeutic options are available. Cryotherapy and curettage are among the options available for isolated lesions. However, it is relatively common for patients to present field cancerization, requiring treatment of the entire area, including 5-fluorouracil (5-FU), imiquimod, ingenol mebutate, or photodynamic therapy (PDT).<a class="elsevierStyleCrossRefs" href="#bib0005"><span class="elsevierStyleSup">1,2</span></a> Evidence regarding which is the most effective treatment is scarce.</p><p id="par0010" class="elsevierStylePara elsevierViewall">Recently, Jansen et al<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> published the results of the first multicenter randomized, blind clinical trial (n = 624), performed in the Netherlands, which compared 5-FU 5% (n = 155) (applied twice daily for 4 weeks), imiquimod 5% (n = 156), ingenol mebutate 0.015% (n = 157), and PDT with methyl aminolevulinate (PDT-MAL) (n = 156). Imiquimod, ingenol mebutate, and PDT-MAL were used in accordance with the product information sheet. The study included adults with 5 AK lesions or more (of any grade) in an area of between 25 and 100 cm<span class="elsevierStyleSup">2</span> on the head or neck. Immunocompromised individuals were excluded from the study. In the first visit, a transparent sheet was drawn over the exact position of the AK lesions to allow for an accurate follow-up. Patients were able to receive up to 2 treatment cycles. The main objective was to evaluate a reduction of 75% or more in the AK lesions after 12 months. Therapeutic failure was defined as failure to achieve this percentage.</p><p id="par0015" class="elsevierStylePara elsevierViewall">An intention-to-treat analysis was performed on the 602 patients with available clinical-response data. The probability of not presenting treatment failure was 74.7% (confidence interval [CI], 66.8–81) with 5-FU, 53.9% (CI, 66.8–81) with imiquimod, 37.7% (CI, 30–45.3) with PDT-MAL, and 28.9% (CI, 21.8–36.3) with ingenol mebutate. The differences between 5-FU and the other treatments were statistically significant. The per-protocol analysis showed similar results. The relative risk of therapeutic failure when compared with 5-FU (hazard ratio = 1) was 2.03 with imiquimod, 2.73 with PDT-MAL, and 3.33 with ingenol mebutate. Satisfaction with treatment and improved quality of life was higher with 5-FU than with the other drugs (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>). Treatment failure after the first treatment cycle was observed in 14.8% with 5-FU, in 37.2% with imiquimod, 34.6% with PDT-MAL, and 47.8% with ingenol mebutate.</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0020" class="elsevierStylePara elsevierViewall">Adherence to treatment exceeded 88% with all treatments. The rate of adverse effects was similar in all groups. However, PDT-MAL was associated with more pain. No associated severe adverse effects were observed and none of the patients suspended the drug for this reason.</p><p id="par0025" class="elsevierStylePara elsevierViewall">This study shows that 5-FU may be superior and have no more adverse effects than other therapeutic alternatives, and patients present a high degree of satisfaction. One of the disadvantages in Spain is the lack of a commercial presentation of 5% 5-FU, which makes it necessary to formulate the drug and may limit its prescription.</p><p id="par0030" class="elsevierStylePara elsevierViewall">5-FU is an effective, safe, and economical alternative in the management of AK. This new evidence demonstrates its superiority to imiquimod, PDT-MAL, and ingenol mebutate.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2019-04-03" "fechaAceptado" => "2019-04-21" "PalabrasClave" => array:1 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec1322155" "palabras" => array:6 [ 0 => "Actinic keratosis" 1 => "Squamous cell carcinoma" 2 => "Fluorouracil" 3 => "5-FU" 4 => "Imiquimod" 5 => "Photodynamic therapy" ] ] ] ] "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Morgado-Carrasco D, Fustà-Novell X, Toll A. FR-Nueva evidencia a favor de 5-fluorouracilo en eltratamiento de lasqueratosis actínicas. Actas Dermosifiliogr. 2021;112:69–70.</p>" ] ] "multimedia" => array:1 [ 0 => array:8 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0005" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:2 [ "leyenda" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Abbreviation: AK indicates actinic keratosis.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " rowspan="3" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Dosage and duration of treatment</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">5% concentration \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Application twice daily for 4 weeks \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Up to 2 treatment cycles \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Reduction ≥75% of AK lesions after 12 months \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">In 82.4% of cases \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Patients who would recommend the treatment \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">83% \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Patients who would undergo retreatment if necessary \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">86.2% \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Good or excellent cosmetic result \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">90.3% \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " rowspan="3" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Adverse effects</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Moderate or severe erythema (81.5%) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Moderate or severe erosions (40%) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Moderate or severe pain (31.9%) \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab2493586.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Characteristics, Treatment Response, and Adverse Effects of Treatment With 5-Fluorouracil in the Clinical Trial by Jansen et al.<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a>.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:3 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Evidence- and consensus-based (S3) Guidelines for the Treatment of Actinic Keratosis - International League of Dermatological Societies in cooperation with the European Dermatology Forum - Short version" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "R.N. Werner" 1 => "E. Stockfleth" 2 => "S.M. Connolly" 3 => "O. Correia" 4 => "R. Erdmann" 5 => "P. Foley" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/jdv.13180" "Revista" => array:6 [ "tituloSerie" => "J Eur Acad Dermatol Venereol" "fecha" => "2015" "volumen" => "29" "paginaInicial" => "2069" "paginaFinal" => "2079" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26370093" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Adaptación española de la Guía europea para la evaluación y tratamiento de la queratosis actínica" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C. Ferrándiz" 1 => "E. Fonseca-Capdevila" 2 => "A. García-Diez" 3 => "C. Guillén-Barona" 4 => "I. Belinchón-Romero" 5 => "P. Redondo-Bellón" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.adengl.2013.11.004" "Revista" => array:6 [ "tituloSerie" => "Actas Dermosifiliogr" "fecha" => "2014" "volumen" => "105" "paginaInicial" => "378" "paginaFinal" => "393" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24725552" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Randomized Trial of Four Treatment Approaches for Actinic Keratosis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M.H.E. Jansen" 1 => "J.P.H.M. Kessels" 2 => "P.J. Nelemans" 3 => "N. Kouloubis" 4 => "A.H.M.M. Arits" 5 => "H.P.A. van Pelt" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa1811850" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2019" "volumen" => "380" "paginaInicial" => "935" "paginaFinal" => "946" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30855743" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/15782190/0000011200000001/v1_202101161046/S1578219020303796/v1_202101161046/en/main.assets" "Apartado" => array:4 [ "identificador" => "34945" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Resident's Forum" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/15782190/0000011200000001/v1_202101161046/S1578219020303796/v1_202101161046/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219020303796?idApp=UINPBA000044" ]
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 5 | 7 | 12 |
| 2024 October | 74 | 39 | 113 |
| 2024 September | 85 | 22 | 107 |
| 2024 August | 105 | 52 | 157 |
| 2024 July | 91 | 33 | 124 |
| 2024 June | 97 | 29 | 126 |
| 2024 May | 77 | 38 | 115 |
| 2024 April | 81 | 37 | 118 |
| 2024 March | 71 | 40 | 111 |
| 2024 February | 59 | 23 | 82 |
| 2024 January | 56 | 33 | 89 |
| 2023 December | 63 | 24 | 87 |
| 2023 November | 80 | 43 | 123 |
| 2023 October | 67 | 23 | 90 |
| 2023 September | 46 | 27 | 73 |
| 2023 August | 39 | 15 | 54 |
| 2023 July | 55 | 35 | 90 |
| 2023 June | 51 | 20 | 71 |
| 2023 May | 51 | 26 | 77 |
| 2023 April | 45 | 38 | 83 |
| 2023 March | 59 | 32 | 91 |
| 2023 February | 45 | 29 | 74 |
| 2023 January | 59 | 54 | 113 |
| 2022 December | 59 | 54 | 113 |
| 2022 November | 23 | 36 | 59 |
| 2022 October | 35 | 25 | 60 |
| 2022 September | 27 | 36 | 63 |
| 2022 August | 23 | 45 | 68 |
| 2022 July | 24 | 41 | 65 |
| 2022 June | 29 | 39 | 68 |
| 2022 May | 59 | 54 | 113 |
| 2022 April | 78 | 42 | 120 |
| 2022 March | 79 | 79 | 158 |
| 2022 February | 63 | 45 | 108 |
| 2022 January | 59 | 54 | 113 |
| 2021 December | 61 | 53 | 114 |
| 2021 November | 62 | 62 | 124 |
| 2021 October | 80 | 80 | 160 |
| 2021 September | 54 | 64 | 118 |
| 2021 August | 50 | 44 | 94 |
| 2021 July | 51 | 48 | 99 |
| 2021 June | 37 | 66 | 103 |
| 2021 May | 55 | 66 | 121 |
| 2021 April | 119 | 112 | 231 |
| 2021 March | 64 | 57 | 121 |
| 2021 February | 74 | 69 | 143 |
| 2021 January | 51 | 40 | 91 |
| 2020 December | 24 | 12 | 36 |
Show all
